As part of the Division of Hematology and Medical Oncology at Weill Cornell Medicine, and NewYork-Presbyterian Brooklyn Methodist Hospital, I care for patients with a broad array of hematologic and oncologic diseases, with a particular focus on gastrointestinal (GI) cancers. I work as part of a multidisciplinary team of cancer experts including surgeons, radiation oncologists, nutritionists and palliative care specialists to create a tailored treatment plan for each patient.
I understand that a cancer diagnosis has a profound physical and emotional impact on the lives of patients, their family members and caregivers. This drives me to deliver compassionate, high-quality and personalized care to each patient, while partnering with them to ensure their needs and goals of care are met along the way.
In addition to patient care, I am fortunate to work alongside a renowned team of clinical investigators to identify new, state-of-the-art treatment strategies for patients with gastrointestinal cancers. I view this work as critical to improving patient outcomes and quality of life.
Specialties and Expertise
- Hematology and Oncology
- Medical Oncology
- Gastrointestinal Cancer
- GI Cancer
- Colon Cancer
- Pancreatic Cancer
- Stomach Cancer
- Gastric Cancer
- Liver Cancer
- Hepatocellular Carcinoma
- Biliary Tract Cancer
- Anal Cancer
- Gastrointestinal Stromal Tumor (GIST)
- Esophageal Cancer
- Neuroendocrine Cancer
Brandon Swed, MD is an Assistant Professor of Clinical Medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and Attending Physician at NewYork-Presbyterian Brooklyn Methodist Hospital. His clinical interest is in gastrointestinal (GI) malignancies. His research is focused on novel therapeutics and drug development for pancreatic cancer.
Dr. Swed received his B.S. in Neuroscience and Chemistry from the University of Miami. He earned his medical degree from the Lewis Katz School of Medicine at Temple University, where he was the recipient of the Weinberger Award for distinction in Hematology and Medical Oncology and was inducted into the Gold Humanism Honor Society. He completed his internship and residency in Internal Medicine at the Hospital of the University of Pennsylvania, where he led several quality improvement initiatives as part of the Healthcare Leadership in Quality program. He continued his medical training at New York-Presbyterian/Weill Cornell Medicine, where he completed his clinical fellowship in Hematology and Medical Oncology, having served as chief fellow during his final year.
Dr. Swed cares for patients with a broad array of hematologic and oncologic diseases, with a particular focus on treating patients with gastrointestinal (GI) cancers. He has also been involved in several translational and clinical research projects focused on novel therapies for pancreatic cancer and was selected to participate in the 2021 AACR-ASCO Methods in Clinical Cancer Research Workshop to further develop this work.
Honors and Awards
Honors and Awards
Healthcare Quality and Safety Leader Award (2019)
American College of Physicians Young Achiever Award (2016)
Emmanuel M. Weinberger Award for Distinction in Hematology/Oncology (2016)
Gold Humanism Honor Society Inductee (2015)
- American Board of Internal Medicine
Clinical and Academic Positions
- Attending Physician - NewYork-Presbyterian/Brooklyn Methodist Hospital
- Assistant Professor of Clinical Medicine - Weill Cornell Medical College, Cornell University
Education and Training
- M.D., Temple University School of Medicine, 2016
- B.S., University of Miami, 2011
Insurance Plans Accepted
For relevant information regarding accepted insurances, please contact this provider directly.
Locations and Appointments
Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.
No External Relationships Reported